Successful Pfizer opposition against ‘Styriagra’ mark affirmed
03-05-2018
TM oppositions against Pfizer suspended amid negotiations
19-04-2018
no_limit_pictures / iStockphoto.com
Medical technology company Biocompatibles UK last week withdrew its oppositions to two trademarks applied for by Pfizer, four months after settlement negotiations.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Trademark Trial and Appeal Board, TTAB, trademark opposition, Pfizer, medical technology,
